Hangzhou, China – July 19, 2024 – AREX Biosciences Ltd. is pleased to announce that it has been officially authorized as a sales distributor for RevMAb Biosciences USA, Inc. antibody products within the territory of China.
RevMAb Biosciences USA, Inc., headquartered in Burlingame, CA, is a leading innovator in the development of high-quality monoclonal antibodies for research and diagnostic applications. The company’s decision to partner with AREX Biosciences Ltd. reflects the growing importance of the Chinese market and AREX's strong capabilities in distribution and customer service within the region.
Under this authorization, AREX Biosciences Ltd. is fully empowered to handle all aspects of product distribution, including but not limited to, submitting tenders, quoting product prices, and providing full access to RevMAb’s extensive range of antibody products.
This strategic partnership underscores AREX Biosciences Ltd.’s position as a key player in the biotechnology distribution network in China, further enhancing its portfolio of high-quality life sciences products.
For more information, please contact:
AREX Biosciences Ltd.
Room 315, Building A, No 525, Xixi Road,
West Lake District, Hangzhou, China 310063
Tel: 400-886-0853
Email: info@arexbio.com
Post time: 2024-10-24 10:03:26
